| This article has been cited by |
| 1 | A very late onset AChR and MuSK double positive myasthenia gravis: a case description and literature review | |
| A. Pugliese,G. Nicocia,S. Messina,A. Toscano,C. Rodolico |
| Neuromuscular Disorders.2023;33(2)145 |
| [DOI] |
|
| 2 | Treatment of anti-MuSK antibody positive myasthenia gravis | |
| Zsuzsanna Pál,Judit Boczán,Benjamin Bereznai,Gábor Lovas,Mária Judit Molnár |
| Orvosi Hetilap.2011;152(39)1586 |
| [DOI] |
|
| 3 | Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine | |
| Konstantinos Poulas,Euphrosyni Koutsouraki,Gregory Kordas,Anna Kokla,Socrates J. Tzartos |
| Journal of Neuroimmunology.2012;250(1-2)94 |
| [DOI] |
|
| 4 | AChR myasthenia gravis switching to MuSK or double antibody positive myasthenia gravis in two children and literature review | |
| Yaru Lu,Hao Ran,Wenhao Yang,Qian Ma,Li Qiu,Changyi Ou,Pei Chen,Zhongqiang Lin,Weibin Liu |
| Neuromuscular Disorders.2020;30(7)534 |
| [DOI] |
|
| 5 | Autoantibodies in acquired myasthenia gravis: Clinical phenotype and immunological correlation | |
| Madhu Nagappa,Anita Mahadevan,Yashwanth Gangadhar,Shripad A. Patil,Suresh Bokolia,Parayil S. Bindu,Sanjib Sinha,Arun B. Taly |
| Acta Neurologica Scandinavica.2019;139(5)428 |
| [DOI] |
|
| 6 | AChR-myasthenia gravis switching to double-seropositive several years after the onset | |
| Vasiliki Zouvelou,Paraskevi Zisimopoulou,Erasmia Psimenou,Eirini Matsigkou,Eleftherios Stamboulis,Socrates J. Tzartos |
| Journal of Neuroimmunology.2014;267(1-2)111 |
| [DOI] |
|
| 7 | AChRAb and MuSKAb double-seropositive myasthenia gravis: a distinct subtype? | |
| Jieni Zhang,Yin Chen,Jiaxin Chen,Xin Huang,Haiyan Wang,Yan Li,Weibin Liu,Huiyu Feng |
| Neurological Sciences.2021;42(3)863 |
| [DOI] |
|
| 8 | Double-seropositive myasthenia gravis | |
| Vasiliki Zouvelou,Stavroula Kyriazi,Michael Rentzos,Maria Belimezi,Maria-Angeliki Micheli,Socrates J. Tzartos,Eleftherios Stamboulis |
| Muscle & Nerve.2013;47(3)465 |
| [DOI] |
|
| 9 | Clinical characteristics of AChRAb and MuSKAb double seropositive myasthenia gravis patients | |
| Mingqiang Li,Lu Ren,Yingna Zhang,Jie Lv,Hua Fang,Jing Zhang,Xue Zhao,Jiaojiao Han,Pengwei Huang,Ying Du,Qingyong Zhang,Junhong Yang,Yunke Zhang,Feng Gao |
| Clinical Neurology and Neurosurgery.2018;172(3)69 |
| [DOI] |
|
